Taylor Bell

495 total citations
11 papers, 125 citations indexed

About

Taylor Bell is a scholar working on Pathology and Forensic Medicine, Genetics and Molecular Biology. According to data from OpenAlex, Taylor Bell has authored 11 papers receiving a total of 125 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 9 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Taylor Bell's work include Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (9 papers) and CAR-T cell therapy research (3 papers). Taylor Bell is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (9 papers) and CAR-T cell therapy research (3 papers). Taylor Bell collaborates with scholars based in United States, China and Czechia. Taylor Bell's co-authors include Hui Zhang, Shengjian Huang, Krystle Nomie, Michael Wang, Shouhao Zhou, Hui Guo, Yang Liu, Liang Zhang, R. Ford and Leo Yu Zhang and has published in prestigious journals such as Blood, Cancer Research and Oncogene.

In The Last Decade

Taylor Bell

10 papers receiving 125 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Taylor Bell United States 5 68 61 60 58 20 11 125
Jared Henderson United States 5 52 0.8× 38 0.6× 45 0.8× 55 0.9× 20 1.0× 14 131
Mark Yan Canada 4 60 0.9× 34 0.6× 25 0.4× 96 1.7× 44 2.2× 8 148
Stefan Köhrer Austria 4 54 0.8× 69 1.1× 41 0.7× 42 0.7× 32 1.6× 11 153
Wayne Rothbaum United States 6 43 0.6× 28 0.5× 64 1.1× 37 0.6× 32 1.6× 13 109
Tobias Roider Germany 8 39 0.6× 67 1.1× 41 0.7× 62 1.1× 18 0.9× 19 175
Sven Turkalj United Kingdom 5 31 0.5× 47 0.8× 40 0.7× 31 0.5× 34 1.7× 9 114
Maité Cabes United Kingdom 5 96 1.4× 41 0.7× 100 1.7× 47 0.8× 18 0.9× 10 139
Christina Sternberg Austria 6 26 0.4× 145 2.4× 18 0.3× 33 0.6× 25 1.3× 6 188
Salvatore Casciaro Italy 9 26 0.4× 110 1.8× 67 1.1× 47 0.8× 82 4.1× 14 183
Lesley Ann Sutton Sweden 5 43 0.6× 33 0.5× 57 0.9× 27 0.5× 31 1.6× 8 113

Countries citing papers authored by Taylor Bell

Since Specialization
Citations

This map shows the geographic impact of Taylor Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taylor Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taylor Bell more than expected).

Fields of papers citing papers by Taylor Bell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taylor Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taylor Bell. The network helps show where Taylor Bell may publish in the future.

Co-authorship network of co-authors of Taylor Bell

This figure shows the co-authorship network connecting the top 25 collaborators of Taylor Bell. A scholar is included among the top collaborators of Taylor Bell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taylor Bell. Taylor Bell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Pham, Lan V., Shengjian Huang, Hui Zhang, et al.. (2018). Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas. Clinical Cancer Research. 24(16). 3967–3980. 63 indexed citations
2.
Guo, Hui, Dongfeng Zeng, Hui Zhang, et al.. (2018). Dual inhibition of PI3K signaling and histone deacetylation halts proliferation and induces lethality in mantle cell lymphoma. Oncogene. 38(11). 1802–1814. 20 indexed citations
3.
Jiang, Changying, Yang Liu, Taylor Bell, et al.. (2018). Pleiotropic Action of Novel Bruton's Tyrosine Kinase Inhibitor BGB-3111 in Mantle Cell Lymphoma. Molecular Cancer Therapeutics. 18(2). 267–277. 20 indexed citations
4.
Huang, Shengjian, Taylor Bell, Yang Liu, et al.. (2017). Abstract 3651: Preclinical examination of the effects of MT-3724, an engineered toxin body targeting CD20, in mantle cell lymphoma. Cancer Research. 77(13_Supplement). 3651–3651.
5.
Zhang, Leo Yu, Lan Pham, Hui Zhang, et al.. (2016). Abstract 4391: Overcoming primary ibrutinib resistance in mantle cell lymphoma. Cancer Research. 76(14_Supplement). 4391–4391. 1 indexed citations
6.
Guo, Hui, Taylor Bell, Shengjian Huang, et al.. (2016). CUDC-907: An Oral HDAC/PI3K Dual Inhibitor with Strong Preclinical Efficacy in MCL Model. Blood. 128(22). 4183–4183. 2 indexed citations
7.
Huang, Shengjian, Loretta J. Nastoupil, Hui Guo, et al.. (2016). Pre-Clinical Evaluation of the PI3K-p110β/δ Inhibitor KA2237 in Mantle Cell Lymphoma. Blood. 128(22). 1837–1837. 4 indexed citations
8.
Zhang, Leo Yu, Lan Pham, Hui Zhang, et al.. (2016). Abstract B18: B-cell lymphoma patient-derived xenograft models: The road to personalized therapy. Clinical Cancer Research. 22(16_Supplement). B18–B18. 1 indexed citations
9.
10.
Liu, Yang, Taylor Bell, Jack Wang, et al.. (2016). Novel Bruton's Tyrosine Kinase Inhibitor Bgb-3111 Demonstrates Potent Activity in Mantle Cell Lymphoma. Blood. 128(22). 5374–5374. 3 indexed citations
11.
Liu, Yang, Taylor Bell, Hui Zhang, et al.. (2016). Targeting Oxphos Pathway Against Ibrutinib Resistance to Mantle Cell Lymphoma. Blood. 128(22). 290–290. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jared Henderson Breakdown of academic impact, for papers by Mark Yan Breakdown of academic impact, for papers by Stefan Köhrer Breakdown of academic impact, for papers by Wayne Rothbaum Breakdown of academic impact, for papers by Tobias Roider Breakdown of academic impact, for papers by Sven Turkalj Breakdown of academic impact, for papers by Maité Cabes Breakdown of academic impact, for papers by Christina Sternberg Breakdown of academic impact, for papers by Salvatore Casciaro Breakdown of academic impact, for papers by Lesley Ann Sutton
Rankless by CCL
2026